Cimetidine-nicoumalone interaction in man: stereochemical considerations
- PMID: 2719902
- PMCID: PMC1379726
- DOI: 10.1111/j.1365-2125.1989.tb05395.x
Cimetidine-nicoumalone interaction in man: stereochemical considerations
Abstract
1. The cimetidine-nicoumalone interaction was studied in five subjects who received a single 10 mg oral dose of racemic nicoumalone alone and 3 days into an oral regimen of cimetidine of 200 mg three times daily and 400 mg at night. 2. The concentrations of R(+)- and S(-)-nicoumalone in plasma were measured using a stereospecific h.p.l.c assay; augmentation of prothrombin time was used as a measure of response. 3. Cimetidine increased the rate (but not extent) of absorption of both R(+)- and S(-)-nicoumalone, and reduced the clearance of R(+)-nicoumalone but not that of the S(-)-enantiomer. 4. Cimetidine increased the anticoagulant response produced by nicoumalone in some but not all subjects, despite a consistent effect on the pharmacokinetics of the oral anti-coagulant. 5. Cimetidine appears to produce its effect by stereoselectively inhibiting the elimination of R(+)-nicoumalone.
Similar articles
-
Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.Br J Clin Pharmacol. 1990 Oct;30(4):616-20. doi: 10.1111/j.1365-2125.1990.tb03822.x. Br J Clin Pharmacol. 1990. PMID: 2291874 Free PMC article.
-
Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man.Br J Clin Pharmacol. 1988 May;25(5):591-8. doi: 10.1111/j.1365-2125.1988.tb03350.x. Br J Clin Pharmacol. 1988. PMID: 3408639 Free PMC article.
-
Cimetidine: interaction with oral anticoagulants in man.Lancet. 1979 Aug 18;2(8138):317-9. doi: 10.1016/s0140-6736(79)90340-4. Lancet. 1979. PMID: 89387 Clinical Trial.
-
Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.Eur J Clin Pharmacol. 1987;32(2):165-72. doi: 10.1007/BF00542190. Eur J Clin Pharmacol. 1987. PMID: 3582481 Clinical Trial.
-
Cisapride. Drug interactions of clinical significance.Drug Saf. 1996 Sep;15(3):167-75. doi: 10.2165/00002018-199615030-00002. Drug Saf. 1996. PMID: 8879971 Review.
Cited by
-
A placebo-controlled pharmacodynamic and pharmacokinetic interaction study between tamsulosin and acenocoumarol.Br J Clin Pharmacol. 2003 Mar;55(3):314-6. doi: 10.1046/j.1365-2125.2003.01793.x. Br J Clin Pharmacol. 2003. PMID: 12630984 Free PMC article. Clinical Trial.
-
Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.Br J Clin Pharmacol. 1990 Oct;30(4):616-20. doi: 10.1111/j.1365-2125.1990.tb03822.x. Br J Clin Pharmacol. 1990. PMID: 2291874 Free PMC article.
-
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.Clin Pharmacokinet. 2005;44(12):1227-46. doi: 10.2165/00003088-200544120-00003. Clin Pharmacokinet. 2005. PMID: 16372822 Review.
-
Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.Br J Pharmacol. 1993 Sep;110(1):482-90. doi: 10.1111/j.1476-5381.1993.tb13836.x. Br J Pharmacol. 1993. PMID: 8220911 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources